Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Amlexanox 40 mg capsule?Dailymed aurobindo quetiapine 300 mg?Quetiapine drug class?Glyxambi price philippines mercury?Vancomycin 1g price philippines mercury drug?
See the DrugPatentWatch profile for ocrevus
Ocrevus is used for treating certain autoimmune diseases that affect the brain and spinal cord, specifically multiple sclerosis (MS). It is approved for both forms of MS: - Relapsing forms of MS (to reduce relapses and disease activity) - Primary progressive MS (to slow disability progression)
Ocrevus (ocrelizumab) is an immunotherapy that targets CD20-positive B cells. By reducing or depleting these immune cells, it helps limit the immune-driven inflammation seen in MS.
Ocrevus is typically considered for people with MS who have: - Relapsing disease activity, or - Primary progressive MS, with the goal of slowing worsening over time
Based on the information provided here, Ocrevus is used for multiple sclerosis (relapsing forms and primary progressive MS).
Other Questions About Ocrevus :